ERT articles & resources on Made-in-China.com

ERT Has Signed an Agreement with MRL

May 20, 2015

Environmental Recycling Technologies (ERT) has signed an agreement with Metallis Recycling (MRL) to form a 50-50 joint venture in the UK. ERT will give the JV exclusive rights to manufacture flat sheet using its proprietary powder ...

Tags: Environmental Recycling Technologies, Metallis Recycling

GSK and Amicus Therapeutics Announce That Amicus Has Received Global Rights

Nov 25, 2013

GlaxoSmithKline (GSK) and Amicus Therapeutics have announced that Amicus has received global rights for the global drug development, regulatory and commercial activities of migalastat HCl as a monotherapy and in combination with enzyme ...

Tags: GlaxoSmithKline, Fabry Agreement

FES International Completed a Contract for Houston-Based Oil and Gas Company,Talos ERT

Nov 19, 2013

Global supplier of fluid transfer systems, FES International, has completed a major £2.4M swivel refurbishment contract for Houston-based oil and gas company, Talos ERT. The swivels form part of a Disconnectable Transfer System ...

Tags: FES, Gulf, Mexico, ERT

Pfizer and Protalix BioTherapeutics Have Obtained Approval for Uplyso

Mar 20, 2013

Pfizer and Protalix BioTherapeutics have obtained approval from the Brazilian National Health Surveillance Agency for Uplyso (alfataliglicerase) as type I Gaucher disease therapy. Uplyso, referred to as Elelyso (taliglucerase alfa) ...

Tags: Pfizer, Protalix, Protalix BioTherapeutics

Protalix BioTherapeutics Has Received Clearance of IND Application From FDA

Dec 6, 2012

Biopharmaceutical company Protalix BioTherapeutics has received clearance of its Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to initiate clinical trials of PRX-102. The Company is planning to ...

Tags: Protalix BioTherapeutics, investigational new drug, IND, PRX-102

FDA Approves Elelyso for Injection to Treat Type 1 Gaucher Disease

Nov 28, 2012

Pfizer and Protalix BioTherapeutics have announced FDA approval of Elelyso (taliglucerase alfa) for injection to treat type 1 Gaucher disease. Elelyso, derived from ProCellEx, is an enzyme replacement therapy (ERT) for the long-term ...

Tags: Protalix/Pfizer Gaucher Drug, Pfizer and Protalix BioTherapeutics